Page results
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
Advice on socialising and managing friendships for young people living with fatigue syndromes.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Bones marrow harvest patient information page.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
File results
-
FOI/2022/0254 - Patient treatment/ surgery
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0267 - Performance data for the CCG2 CQUIN - Antibiotic prescribing for UTI in adults aged 16+
-
FOI/2022/0270 - Local care record/ shared care record implementation
-
FOI/2022/0274 - Patient treatment for various conditions
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0278 - Surgical tables in use at Trust
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0282 - Decontamination and infection control leads; risk assessment group meetings